Bone mineral density and bone turnover markers in patients receiving a single course of isotretinoin for nodulocystic acne

Tekin N. S., ÖZDOLAP S., SARIKAYA S., Keskin S.

INTERNATIONAL JOURNAL OF DERMATOLOGY, vol.47, no.6, pp.622-625, 2008 (SCI-Expanded) identifier identifier identifier


Background High-dose isotretinoin has been reported to have adverse effects on bone mineral density (BMD); however, studies evaluating changes in BMD with isotretinoin therapy at different dosages and with varying treatment durations have produced conflicting results.